Standout Papers
- Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer (2009)
- Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA (2014)
- Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study (2018)
- MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression (2016)
Immediate Impact
1 by Nobel laureates 19 from Science/Nature 133 standout
Citing Papers
Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial
2023 Standout
Lung cancer
2021 Standout
Works of David M. Jackman being referenced
Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer
2015
Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| David M. Jackman | 5496 | 4838 | 1636 | 2003 | 87 | 7.4k | |
| Rogério Lilenbaum | 5344 | 5515 | 1208 | 2115 | 105 | 8.3k | |
| Chun‐Ming Tsai | 6266 | 5227 | 1400 | 2013 | 112 | 7.6k | |
| Haiyi Jiang | 8090 | 6737 | 2048 | 2342 | 52 | 9.7k | |
| Caicun Zhou | 6649 | 6319 | 1614 | 2518 | 135 | 8.7k | |
| Alan B. Sandler | 3602 | 4405 | 1026 | 2405 | 107 | 7.4k | |
| Rafael Rosell | 4708 | 4198 | 1677 | 3198 | 142 | 7.9k | |
| В. А. Горбунова | 5438 | 4426 | 1421 | 2215 | 59 | 7.0k | |
| Hisayuki Shigematsu | 5189 | 4169 | 1522 | 2901 | 73 | 7.0k | |
| Helen Mann | 4433 | 4000 | 1192 | 1592 | 89 | 5.9k | |
| Renato Martins | 4717 | 4841 | 932 | 1810 | 40 | 6.9k |
All Works
Loading papers...